US$ 26.75
glp 1 and crohn's disease GLP-1 drugs calm inflammation beyond diabetes weight loss The alleviating effect and mechanism
Description
And better decisions support long-term health
Weight Support*

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy

Independent editorial review
